Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Lugalbanda
    Junior Member
    • Oct 2016
    • 3

    DESeq factor design, and optimal number of samples

    For the 1st question, I want to know if I should run a single factor or double factor. These samples are match normal/tumor from different patients so something like this

    p1N p1T p2N p2T p3N p3T

    do i have to run a double factor run like this:

    ------------condition---------patientNumber
    ------------<factor>--------- <factor>
    p1N--------normal------------ 1
    p1T----------tumor ------------1
    p2N---------normal-------------2
    p2T----------tumor--------------2
    p3N--------normal-------------3
    p3T---------tumor--------------3


    or a single factor like this:

    -------------Condition
    -------------<factor>
    p1N--------normal
    p1T---------tumor
    p2N--------normal
    p2T---------tumor
    p3N--------normal
    p3T---------tumor


    I suppose the question boils down to whether or not DESeq cares if samples come from different patients.

    For the 2nd question, I have a thousand match normal/tumor from the same type of tissue but from different patients, should I run DESeq on all one thousand of them or is it fine to do a smaller amount like one hundred?
    Last edited by Lugalbanda; 10-05-2016, 01:53 PM. Reason: formatting
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    If you have tumour/normal pairs, then you should include the pairing information

    Code:
    design = ~patientNumber + condition
    DESeq2 (there's no reason to use DESeq) can get rather slow with 1000 samples. You'd be better with limma in that case.

    Comment

    • SylvainL
      Senior Member
      • Feb 2012
      • 180

      #3
      Hi dpryan,

      how slow for 1000 samples?

      Comment

      • dpryan
        Devon Ryan
        • Jul 2011
        • 3478

        #4
        @SylvainL: Good question and I don't know the answer to that. Perhaps Mike Love will pop by the thread and give a guesstimate.

        Comment

        • fanli
          Senior Member
          • Jul 2014
          • 197

          #5
          It seems from the cancer literature that most/all studies using a paired tumor-normal design only have one sample from each (e.g. p1T, p1N) and not in replicate (e.g. p1Ta, p1Tb, p1Tc, p1Na, p1Nb, p1Nc). Is that appropriate, or would it be better to do things in triplicate? Say by splitting a tumor sample into 3 sections?

          Comment

          • SylvainL
            Senior Member
            • Feb 2012
            • 180

            #6
            Your replicates are paired (p1T, p1N, p2T, p2N, etc...) so there is no need to split.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              From Collection to Sequencing: Why Sample Preparation and Preservation Define Sequencing Data
              by SEQadmin2


              Data variability is still an issue in sequencing technologies despite the advances in reproducibility and accuracy of these platforms. But the problem does not originate in the sequencing itself, but in the previous steps, before the sample reaches the sequencer.


              The first step is collection, followed by preservation and sample preparation for analysis. Most scientists overlook those steps, but not being careful might just be skewing the experiment’s results.
              ...
              06-02-2026, 10:05 AM
            • SEQadmin2
              Single-Cell Sequencing at an Inflection Point: Early Impacts of New Platforms and Emerging Trends
              by SEQadmin2


              With the launch of new single-cell sequencing platforms in 2026, the field stands at an exciting inflection point. This article surveys the most impactful advances in the field and discusses how they’re reshaping research in cancer, immunology, and beyond.


              Introduction

              Single-cell sequencing technologies have undergone remarkable advances over the past decade, transitioning from low-throughput experimental approaches to highly scalable platforms capable of...
              05-22-2026, 06:42 AM
            • SEQadmin2
              Environmental Genomics in the Age of NGS: From Microbes to Conservation Strategies
              by SEQadmin2

              Studying ecosystems means dealing with complex, multi-species communities that are hard to observe at scale. This complexity, however, hides many important questions to be answered, from how biogeochemical cycles work and how climate change can affect species distribution to how conservation strategies can work best.


              Genomics, particularly since the expansion of NGS, has transformed ecosystem ecology. By sequencing environmental DNA, we can now assess biodiversity without direct...
              05-06-2026, 09:04 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Yesterday, 08:59 AM
            0 responses
            13 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 06-02-2026, 12:03 PM
            0 responses
            21 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 06-02-2026, 11:40 AM
            0 responses
            18 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 05-28-2026, 11:40 AM
            0 responses
            31 views
            0 reactions
            Last Post SEQadmin2  
            Working...